14JUN

18 scientists move west to UK labs

2 min read

16:35UTC

DSIT reported on 5 June that 18 researchers had joined UK institutions via the £54m UKRI Global Talent Fund, recruited from Stanford, Yale, Columbia and elsewhere as American federal science budgets contract.

← Back to London startup raises Britain's own AI model Jump to analysis ↓

TechnologyDeveloping

Key takeaway

British labs are pulling senior US-based scientists west as American federal science funding contracts.

DSIT reported on Friday 5 June that ten more researchers had joined UK institutions through the UKRI Global Talent Fund, a £54m pot administered by UK Research and Innovation (UKRI), taking the running total to 18. The named recruits left posts at Oregon State, Stanford, Columbia, UC San Diego, Yale and Tel Aviv. Professor Bryony DuPont moved from Oregon State to Strathclyde for AI in energy systems; Professor Laura Huckins left Yale for Bath to work on psychiatric genetics. ¹

The timing tracks cuts to United States federal Science budgets under the current administration, which have left researchers looking for stable funding abroad. These are placements, not promises: named people in named labs, expected to seed spinout activity over the coming years. Not every recruit founds a company, and the fund buys research capacity rather than guaranteed ventures.

The Advanced Research and Invention Agency (ARIA), the UK's high-risk research funder modelled on DARPA, reported a sharper conversion from its Encode fellowship, which pays researchers to spin out companies. Two proto-companies emerged from 18 fellows in four months, after which the government added £5m to double the cohort.

Britain signed a researcher-mobility deal with France in May, committing annual funding to early-career exchange . The Global Talent Fund and ARIA are the domestic side of the same effort, moving people as well as money into UK Science.

Deep Analysis

In plain English

American universities and research labs have been cutting positions as the US federal science budget shrinks under the current administration. Some of those researchers are choosing to move abroad. The UK government set up a £54m fund specifically to recruit senior scientists from overseas. In the first wave, 18 researchers moved from Stanford, Columbia, Yale, and other American and Israeli institutions into UK university labs. Separately, ARIA, a UK agency modelled on the American DARPA programme, ran a four-month fellowship that explicitly allowed researchers to spend time founding companies. Two of the 18 fellows who went through the programme started proto-companies, which is an unusually high rate.

Deep Analysis

Root Causes

The US National Institutes of Health lost approximately $2bn in funding commitments in the first quarter of 2025 following Congressional budget reconciliation. The National Science Foundation faced a further 10% proposed cut in the 2026 federal budget request. These cuts affect postdoctoral and early-career researchers most severely, because their positions depend on grant renewal rather than tenure.

UK salary competitiveness has also improved relative to the US for mid-career researchers. The weak dollar (USD/GBP at 0.79 in May 2026) means a UK salary in sterling buys more in US-dollar terms than at any point since 2014, reducing the financial penalty of moving west.

ARIA's Encode fellowship operates differently from UKRI grant mechanisms: fellows receive a fixed-term stipend with explicit permission to spend time on company formation, removing the conflict-of-interest constraint that blocks most UK university researchers from serious commercialisation activity during their grant periods.

What could happen next?

Opportunity
UK deep-tech companies now have a pool of recently-arrived senior US-trained scientists at UK institutions who are institutionally primed for commercial collaboration.
Short term · Assessed
Risk
If US federal science funding stabilises or recovers, the talent flow reverses: researchers recruited under time-limited packages may return to American institutions when their UK terms end.
Medium term · Assessed
Consequence
ARIA's 11% company-formation rate from the Encode cohort gives the agency a stronger case than any UK university technology transfer office for running the next wave of commercialisation funding.
Short term · Assessed

Sources:UK Tech News

Mentions:UKRI →Advanced Research and Invention Agency →DSIT →Oregon →DARPA →Tel Aviv →San Diego →France →United States →UKRI Global Talent Fund →ARIA's Encode fellowship →

First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026

Read original →

Causes and effects

Caused by

UK and France sign science pact

UK-France researcher-mobility deal in May established the bilateral talent framework that runs alongside the UKRI Global Talent Fund domestic recruitment.

Occurred 29 May 2026

Read story →

This Event

18 scientists move west to UK labs

Named scientists placed in named UK labs show an active recruitment pipeline running west across the Atlantic, not a hypothetical one.

Led to

BBSRC backs 21 Fellows with £10m

UKRI's Global Talent Fund placed 18 international researchers in UK labs; BBSRC's 21 Fellows investment is the same talent-pipeline logic applied one rung earlier in the researcher career.

Occurred 18 Jun 2026

Read story →

Different Perspectives

Fubon Financial

Fubon Financial joined Humanoid's Series A on 21 July as a minority financial investor alongside Schaeffler and Bosch, who also hold the customer and manufacturer roles. A pure-play investor from Taipei is pricing a London robot maker on terms two German industrial groups effectively set.

NATO Innovation Fund

The Fund joined Greenjets' £30m Series A on 21 July alongside NSSIF, betting on ducted electric propulsion's civil market to fund a technology with an obvious defence application. It is backing a company that took twenty-one years to reach this stage, on the expectation that certification-cycle timelines reward patient capital over a quick return.

Prime Movers Lab

Prime Movers Lab led Humanoid's Series A on 21 July as the round's only pure financial investor, sharing the cap table with two co-investors who are also the anchor customer and the factory. That leaves the fund's usual arm's-length pricing role diluted by partners with a direct commercial stake in the valuation holding up.

Bosch and Schaeffler

Schaeffler signed what Humanoid calls the industry's largest publicly announced commercial agreement, while Bosch took equity and became contract manufacturer, filling capacity a shrinking combustion supply chain freed. Neither company has disclosed a unit count or an invoice, so their public commitment stops well short of Forbes' 100,000-unit projection.

UK founders raising seed through Series A

A London robotics founder raised $152m this week against a signed industrial customer and a reserved factory, while a Cornwall founder more typically draws a £25,000 loan from a regional fund manager. Both call it British venture funding, but one route runs through Bosch's production line and the other through diligence built for businesses too small for any VC's attention.

EQT

EQT was reported on 3 July to be in advanced talks for a further CuspAI stake on behalf of the EU's Scaleup Europe Fund, but does not appear on the round CuspAI closed. Whether Europe's own sovereign vehicle secured a position, was outbid, or withdrew is unresolved.